IMC Chicago
LABD icon

IMC Chicago’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

IMC Chicago’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,486
Closed -$168K – 6582
2026
Q1 		$204K Buy
+12,486
New +$236K ﹤0.01% 4994
2024
Q1 		– Sell
-10,513
Closed -$1.02M – 2434
2023
Q4 		$1.02M Buy
+10,513
New +$2.05M ﹤0.01% 1431
2023
Q1 		– Sell
-6,658
Closed -$1.15M – 1334
2022
Q4 		$1.15M Buy
+6,658
New +$1.36M ﹤0.01% 971
2020
Q4 		– Sell
-2,018
Closed -$1.2M – 1078
2020
Q3 		$1.2M Buy
+2,018
New +$1.3M ﹤0.01% 693
2020
Q1 		– Sell
-1,398
Closed -$3.45M – 874
2019
Q4 		$3.45M Buy
1,398
+1,177
+533% +$4.18M 0.01% 411
2019
Q3 		$1.12M Buy
+221
New +$910K ﹤0.01% 551

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

IMC Chicago's LABD Position: Q2 2026 in Review

IMC Chicago sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026, closing a stake of 12,486 shares — an estimated $168K sold.

IMC Chicago first reported a position in LABD in Q3 2019 and held it in 6 quarters. The position peaked at $3.45M in Q4 2019. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • IMC Chicago reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 12,486 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $168K.
  • IMC Chicago first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2019 and held it in 6 quarters.
  • IMC Chicago's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $3.45M in Q4 2019.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.